drugset / Trial / NCT00285727

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression

NCT00285727

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is an 8 week study for patients who are currently taking antidepressant medication but not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant medication. Patients come into the clinic once a week when starting on the medication and then once every other week for the remainder of the 8 weeks.

Timeline

Start
2006-01
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule